Bioenergetics and synaptic plasticity as potential targets for individualizing treatment for depression

J. Blair Price, Carrie Bronars, Sophie Erhardt, Kathyrn R. Cullen, Lilly Schwieler, Michael Berk, Ken Walder, Sean L. McGee, Mark A Frye, Susannah J Tye

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Disruptions of bioenergetic signaling and neurogenesis are hallmarks of depression physiology and are often the product of dysregulation of the inflammatory, stress-response, and metabolic systems. These systems are extensively interrelated at the physiological level, yet the bulk of the literature to date addresses pathophysiological mechanisms in isolation. A more integrated understanding of the etiology, progression, and treatment response profiles of depression is possible through wider consideration of relevant preclinical and clinical studies that examine the result of disruptions in these systems. Here, we review recent data demonstrating the critical effects of bioenergetic disruption on neuroplasticity and the development and progression of depressive illness. We further highlight the interactive and dynamic nature of the inflammatory and stress response systems and how disruption of these systems influences bioenergetic signaling pathways critical to treatment outcomes. In so doing, we underscore the pressing need to reconsider the implications of treatment resistance and present a framework for developing novel, personalized treatment approaches for depression.

Original languageEnglish (US)
Pages (from-to)212-220
Number of pages9
JournalNeuroscience and Biobehavioral Reviews
Volume90
DOIs
StatePublished - Jul 1 2018

Fingerprint

Neuronal Plasticity
Energy Metabolism
Physiological Stress
Critical Pathways
Neurogenesis

Keywords

  • Bioenergetics
  • Bipolar disorder (BD)
  • Brain-derived neurotrophic factor (BDNF)
  • Hypothalamic-pituitary-adrenal axis (HPA axis)
  • Inflammation
  • Kynurenine
  • Major depressive disorder (MDD)
  • Mammalian target of rapamycin (mTOR)
  • Metabolism
  • Proinflammatory cytokine
  • Stress

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology
  • Cognitive Neuroscience
  • Behavioral Neuroscience

Cite this

Bioenergetics and synaptic plasticity as potential targets for individualizing treatment for depression. / Price, J. Blair; Bronars, Carrie; Erhardt, Sophie; Cullen, Kathyrn R.; Schwieler, Lilly; Berk, Michael; Walder, Ken; McGee, Sean L.; Frye, Mark A; Tye, Susannah J.

In: Neuroscience and Biobehavioral Reviews, Vol. 90, 01.07.2018, p. 212-220.

Research output: Contribution to journalReview article

Price, JB, Bronars, C, Erhardt, S, Cullen, KR, Schwieler, L, Berk, M, Walder, K, McGee, SL, Frye, MA & Tye, SJ 2018, 'Bioenergetics and synaptic plasticity as potential targets for individualizing treatment for depression', Neuroscience and Biobehavioral Reviews, vol. 90, pp. 212-220. https://doi.org/10.1016/j.neubiorev.2018.04.002
Price, J. Blair ; Bronars, Carrie ; Erhardt, Sophie ; Cullen, Kathyrn R. ; Schwieler, Lilly ; Berk, Michael ; Walder, Ken ; McGee, Sean L. ; Frye, Mark A ; Tye, Susannah J. / Bioenergetics and synaptic plasticity as potential targets for individualizing treatment for depression. In: Neuroscience and Biobehavioral Reviews. 2018 ; Vol. 90. pp. 212-220.
@article{78fd1ccc64e848588bdb12a405cc919e,
title = "Bioenergetics and synaptic plasticity as potential targets for individualizing treatment for depression",
abstract = "Disruptions of bioenergetic signaling and neurogenesis are hallmarks of depression physiology and are often the product of dysregulation of the inflammatory, stress-response, and metabolic systems. These systems are extensively interrelated at the physiological level, yet the bulk of the literature to date addresses pathophysiological mechanisms in isolation. A more integrated understanding of the etiology, progression, and treatment response profiles of depression is possible through wider consideration of relevant preclinical and clinical studies that examine the result of disruptions in these systems. Here, we review recent data demonstrating the critical effects of bioenergetic disruption on neuroplasticity and the development and progression of depressive illness. We further highlight the interactive and dynamic nature of the inflammatory and stress response systems and how disruption of these systems influences bioenergetic signaling pathways critical to treatment outcomes. In so doing, we underscore the pressing need to reconsider the implications of treatment resistance and present a framework for developing novel, personalized treatment approaches for depression.",
keywords = "Bioenergetics, Bipolar disorder (BD), Brain-derived neurotrophic factor (BDNF), Hypothalamic-pituitary-adrenal axis (HPA axis), Inflammation, Kynurenine, Major depressive disorder (MDD), Mammalian target of rapamycin (mTOR), Metabolism, Proinflammatory cytokine, Stress",
author = "Price, {J. Blair} and Carrie Bronars and Sophie Erhardt and Cullen, {Kathyrn R.} and Lilly Schwieler and Michael Berk and Ken Walder and McGee, {Sean L.} and Frye, {Mark A} and Tye, {Susannah J}",
year = "2018",
month = "7",
day = "1",
doi = "10.1016/j.neubiorev.2018.04.002",
language = "English (US)",
volume = "90",
pages = "212--220",
journal = "Neuroscience and Biobehavioral Reviews",
issn = "0149-7634",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Bioenergetics and synaptic plasticity as potential targets for individualizing treatment for depression

AU - Price, J. Blair

AU - Bronars, Carrie

AU - Erhardt, Sophie

AU - Cullen, Kathyrn R.

AU - Schwieler, Lilly

AU - Berk, Michael

AU - Walder, Ken

AU - McGee, Sean L.

AU - Frye, Mark A

AU - Tye, Susannah J

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Disruptions of bioenergetic signaling and neurogenesis are hallmarks of depression physiology and are often the product of dysregulation of the inflammatory, stress-response, and metabolic systems. These systems are extensively interrelated at the physiological level, yet the bulk of the literature to date addresses pathophysiological mechanisms in isolation. A more integrated understanding of the etiology, progression, and treatment response profiles of depression is possible through wider consideration of relevant preclinical and clinical studies that examine the result of disruptions in these systems. Here, we review recent data demonstrating the critical effects of bioenergetic disruption on neuroplasticity and the development and progression of depressive illness. We further highlight the interactive and dynamic nature of the inflammatory and stress response systems and how disruption of these systems influences bioenergetic signaling pathways critical to treatment outcomes. In so doing, we underscore the pressing need to reconsider the implications of treatment resistance and present a framework for developing novel, personalized treatment approaches for depression.

AB - Disruptions of bioenergetic signaling and neurogenesis are hallmarks of depression physiology and are often the product of dysregulation of the inflammatory, stress-response, and metabolic systems. These systems are extensively interrelated at the physiological level, yet the bulk of the literature to date addresses pathophysiological mechanisms in isolation. A more integrated understanding of the etiology, progression, and treatment response profiles of depression is possible through wider consideration of relevant preclinical and clinical studies that examine the result of disruptions in these systems. Here, we review recent data demonstrating the critical effects of bioenergetic disruption on neuroplasticity and the development and progression of depressive illness. We further highlight the interactive and dynamic nature of the inflammatory and stress response systems and how disruption of these systems influences bioenergetic signaling pathways critical to treatment outcomes. In so doing, we underscore the pressing need to reconsider the implications of treatment resistance and present a framework for developing novel, personalized treatment approaches for depression.

KW - Bioenergetics

KW - Bipolar disorder (BD)

KW - Brain-derived neurotrophic factor (BDNF)

KW - Hypothalamic-pituitary-adrenal axis (HPA axis)

KW - Inflammation

KW - Kynurenine

KW - Major depressive disorder (MDD)

KW - Mammalian target of rapamycin (mTOR)

KW - Metabolism

KW - Proinflammatory cytokine

KW - Stress

UR - http://www.scopus.com/inward/record.url?scp=85046342717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046342717&partnerID=8YFLogxK

U2 - 10.1016/j.neubiorev.2018.04.002

DO - 10.1016/j.neubiorev.2018.04.002

M3 - Review article

VL - 90

SP - 212

EP - 220

JO - Neuroscience and Biobehavioral Reviews

JF - Neuroscience and Biobehavioral Reviews

SN - 0149-7634

ER -